219 related articles for article (PubMed ID: 28645479)
1. Impact of the NAP-1 strain on disease severity, mortality, and recurrence of healthcare-associated Clostridium difficile infection.
Bauer KA; Johnston JEW; Wenzler E; Goff DA; Cook CH; Balada-Llasat JM; Pancholi P; Mangino JE
Anaerobe; 2017 Dec; 48():1-6. PubMed ID: 28645479
[TBL] [Abstract][Full Text] [Related]
2. Clostridium difficile infection (CDI) severity and outcome among patients infected with the NAP1/BI/027 strain in a non-epidemic setting.
Scardina T; Labuszewski L; Pacheco SM; Adams W; Schreckenberger P; Johnson S
Infect Control Hosp Epidemiol; 2015 Mar; 36(3):280-6. PubMed ID: 25695169
[TBL] [Abstract][Full Text] [Related]
3. NAP1 strain type predicts outcomes from Clostridium difficile infection.
See I; Mu Y; Cohen J; Beldavs ZG; Winston LG; Dumyati G; Holzbauer S; Dunn J; Farley MM; Lyons C; Johnston H; Phipps E; Perlmutter R; Anderson L; Gerding DN; Lessa FC
Clin Infect Dis; 2014 May; 58(10):1394-400. PubMed ID: 24604900
[TBL] [Abstract][Full Text] [Related]
4. Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality.
Miller M; Gravel D; Mulvey M; Taylor G; Boyd D; Simor A; Gardam M; McGeer A; Hutchinson J; Moore D; Kelly S
Clin Infect Dis; 2010 Jan; 50(2):194-201. PubMed ID: 20025526
[TBL] [Abstract][Full Text] [Related]
5. The evolving epidemiology of
Katz KC; Golding GR; Choi KB; Pelude L; Amaratunga KR; Taljaard M; Alexandre S; Collet JC; Davis I; Du T; Evans GA; Frenette C; Gravel D; Hota S; Kibsey P; Langley JM; Lee BE; Lemieux C; Longtin Y; Mertz D; Mieusement LMD; Minion J; Moore DL; Mulvey MR; Richardson S; Science M; Simor AE; Stagg P; Suh KN; Taylor G; Wong A; Thampi N;
CMAJ; 2018 Jun; 190(25):E758-E765. PubMed ID: 29941432
[TBL] [Abstract][Full Text] [Related]
6. Clostridium difficile infection: Description of NAP1/027 and non NAP1/027 strains in a high complexity center in Cali, Colombia, 2012-2015.
Oñate-Gutiérrez JM; Segura J; Correa A; Cantor E; Villegas MV
Biomedica; 2019 May; 39(s1):63-70. PubMed ID: 31529849
[TBL] [Abstract][Full Text] [Related]
7. Association of healthcare exposure with acquisition of different Clostridium difficile strain types in patients with recurrent infection or colonization after clinical resolution of initial infection.
Thabit AK; Housman ST; Burnham CD; Nicolau DP
J Hosp Infect; 2016 Feb; 92(2):167-72. PubMed ID: 26792686
[TBL] [Abstract][Full Text] [Related]
8. Clostridium difficile outbreak caused by NAP1/BI/027 strain and non-027 strains in a Mexican hospital.
Morfin-Otero R; Garza-Gonzalez E; Aguirre-Diaz SA; Escobedo-Sanchez R; Esparza-Ahumada S; Perez-Gomez HR; Petersen-Morfin S; Gonzalez-Diaz E; Martinez-Melendez A; Rodriguez-Noriega E;
Braz J Infect Dis; 2016; 20(1):8-13. PubMed ID: 26620948
[TBL] [Abstract][Full Text] [Related]
9. Risk factors and outcomes associated with severe clostridium difficile infection in children.
Kim J; Shaklee JF; Smathers S; Prasad P; Asti L; Zoltanski J; Dul M; Nerandzic M; Coffin SE; Toltzis P; Zaoutis T
Pediatr Infect Dis J; 2012 Feb; 31(2):134-8. PubMed ID: 22031485
[TBL] [Abstract][Full Text] [Related]
10. [Characteristics of Clostridium difficile infection in a high complexity hospital and report of the circulation of the NAP1/027 hypervirulent strain in Colombia].
Gualtero SM; Abril LA; Camelo N; Sanchez SD; Davila FA; Arias G; Silva E; Bustos IG; Josa DF; Torres IC; Zambrano LC; Pareja MJ
Biomedica; 2017 Dec; 37(4):466-472. PubMed ID: 29373767
[TBL] [Abstract][Full Text] [Related]
11. Impact of Clostridium difficile infection caused by the NAP1/RT027 strain on severity and recurrence during an outbreak and transition to endemicity in a Mexican tertiary care center.
Tamez-Torres KM; Torres-González P; Leal-Vega F; García-Alderete A; López García NI; Mendoza-Aguilar R; Galindo-Fraga A; Bobadilla-Del Valle M; Ponce de León A; Sifuentes-Osornio J
Int J Infect Dis; 2017 Dec; 65():44-49. PubMed ID: 28986313
[TBL] [Abstract][Full Text] [Related]
12. Clinical Utility of Laboratory Detection of Clostridium difficile Strain BI/NAP1/027.
Kociolek LK; Gerding DN
J Clin Microbiol; 2016 Jan; 54(1):19-24. PubMed ID: 26511742
[TBL] [Abstract][Full Text] [Related]
13. Burden of Clostridium difficile infection between 2010 and 2013: Trends and outcomes from an academic center in Eastern Europe.
Kurti Z; Lovasz BD; Mandel MD; Csima Z; Golovics PA; Csako BD; Mohas A; Gönczi L; Gecse KB; Kiss LS; Szathmari M; Lakatos PL
World J Gastroenterol; 2015 Jun; 21(21):6728-35. PubMed ID: 26074711
[TBL] [Abstract][Full Text] [Related]
14. Clostridium difficile strain NAP-1 is not associated with severe disease in a nonepidemic setting.
Cloud J; Noddin L; Pressman A; Hu M; Kelly C
Clin Gastroenterol Hepatol; 2009 Aug; 7(8):868-873.e2. PubMed ID: 19465153
[TBL] [Abstract][Full Text] [Related]
15. PCR based detection of tcdCΔ117 in Clostridium difficile infection identifies patients at risk for recurrence - A hospital-based prospective observational study.
Jazmati N; Hain O; Hellmich M; Plum G; Kaasch A
Anaerobe; 2019 Jun; 57():39-44. PubMed ID: 30878603
[TBL] [Abstract][Full Text] [Related]
16. Clostridium difficile infection in children hospitalized due to diarrhea.
Dulęba K; Pawłowska M; Wietlicka-Piszcz M
Eur J Clin Microbiol Infect Dis; 2014 Feb; 33(2):201-9. PubMed ID: 24213847
[TBL] [Abstract][Full Text] [Related]
17. Binary toxin and its clinical importance in Clostridium difficile infection, Belgium.
Pilate T; Verhaegen J; Van Ranst M; Saegeman V
Eur J Clin Microbiol Infect Dis; 2016 Nov; 35(11):1741-1747. PubMed ID: 27393490
[TBL] [Abstract][Full Text] [Related]
18. First report of Clostridium difficile NAP1/027 in a Mexican hospital.
Camacho-Ortiz A; López-Barrera D; Hernández-García R; Galván-De Los Santos AM; Flores-Treviño SM; Llaca-Díaz JM; Maldonado-Garza HJ; Bosques-Padilla FJ; Garza-González E
PLoS One; 2015; 10(4):e0122627. PubMed ID: 25915544
[TBL] [Abstract][Full Text] [Related]
19. Clostridium difficile infection after allogeneic hematopoietic stem cell transplant: strain diversity and outcomes associated with NAP1/027.
Kamboj M; Xiao K; Kaltsas A; Huang YT; Sun J; Chung D; Wu S; Sheahan A; Sepkowitz K; Jakubowski AA; Papanicolaou G
Biol Blood Marrow Transplant; 2014 Oct; 20(10):1626-33. PubMed ID: 24973628
[TBL] [Abstract][Full Text] [Related]
20. Clinical manifestations of Clostridium difficile infection in a medical center in Taiwan.
Lai CC; Lin SH; Tan CK; Liao CH; Huang YT; Hsueh PR
J Microbiol Immunol Infect; 2014 Dec; 47(6):491-6. PubMed ID: 23978490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
